Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07088783
Active, not recruiting Not applicable

Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients

NCT07088783 · tracked via the Priya Life Science Turkey tracker
Sponsor
Ozlem
Phase
Not applicable
Started
2024-06-01
Last updated
2025-07-28

Condition(s) studied

Multiple Myeloma (MM)Self-careQuality of Life

Investigational drug(s) / intervention(s)

Mobile App Education

Mobile App Education: A 24-week self-care education delivered via a mobile application based on Orem's Self-Care Model

Study summary

This randomized controlled trial aims to assess the effectiveness of a mobile application-based education program, developed according to Orem's Self-Care Model, in improving self-care agency and quality of life among patients with multiple myeloma in Turkey. Participants are recruited from the outpatient clinic of a hospital and randomly assigned to either the intervention or control group. The intervention group uses the mobile application for 24 weeks, while the control group continues with routine care and receives a standard one-page brochure commonly distributed to cancer patients. All participants complete a demographic form, the EORTC QLQ-C30, QLQ-MY20, and the Self-Care Agency Scale at baseline, week 12, and week 24. The collected data will be used to compare changes in self-care agency and quality of life between the two groups over time.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with multiple myeloma and received at least one course of treatment * Age 18 or older * Able to speak and read Turkish * ECOG performance status of I, II, or III * Has used at least one Android-based digital tool (e.g., sending text messages, email, using mobile apps) * Literate (able to read and write) * Willing to participate and able to provide written informed consent Exclusion Criteria: * Not currently diagnosed with multiple myeloma * Has cognitive or psychological disorders that prevent completing questionnaires or using the mobile application * Unable to speak or understand Turkish * Unwilling or unable to provide written informed consent

Primary outcome measure(s)

  • Change in Self-Care Agency Score — Baseline, 12th week, and 24th week
    Self-care agency was assessed using the Self-Care Agency Scale.

Trial sites (1)

FacilityCityRegionStatus
Dokuz Izmir Turkey (Türkiye)

Other trials for the same condition

The Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological Cancers Starting soon
Effects of Physical Activity Training on Physical Fitness and Quality of Life in Paramedic Students Active, not recruiting
Mindfulness-Based Education For Women With Polycystic Ovary Syndrome Recruiting
Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study Active, not recruiting
Effect of Yoga Program on Quality of Life in Women With Breast Cancer Receiving Endocrine Therapy Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07088783 on ClinicalTrials.gov ↗ ← All trials in Turkey